Part of a comprehensive analysis of the Medicines Act 1975
All Parts in This Series
Key Provisions and Their Purpose Under the Medicines Act 1975
The Medicines Act 1975 establishes a comprehensive regulatory framework governing the licensing, manufacture, sale, and export of medicinal products in Singapore. The key provisions serve to ensure public safety, maintain product quality, and regulate the pharmaceutical industry effectively.
"The authority responsible for the grant, renewal, variation, suspension and revocation of licences and certificates is—(a) except as provided in paragraph (b), the Chief Executive of the Authority; and (b) the Director‑General, Animal Health and Welfare... [4]."
Verify source in source document →
Section 4 designates the licensing authority, primarily the Chief Executive of the Authority, with a specific exception for veterinary-related matters assigned to the Director-General, Animal Health and Welfare. This provision centralizes regulatory control, ensuring accountability and consistency in licensing decisions.
"Except in accordance with a licence granted for the purposes of this section (called in this Act a product licence) a person must not... sell, supply or export any medicinal product... [5(1)]."
Verify source in source document →
Section 5 prohibits the sale, supply, export, procurement for sale, or manufacture of medicinal products without a valid product licence. This restriction exists to prevent unregulated distribution of medicinal products, thereby protecting consumers from unsafe or unapproved medicines.
"A person must not manufacture or assemble any medicinal product except in accordance with a licence granted for the purposes of this subsection (called in this Act a manufacturer’s licence)... [6(2)]."
Verify source in source document →
Section 6 imposes a licensing requirement on manufacturers and wholesale dealers of medicinal products. This ensures that only qualified entities with appropriate facilities and standards can produce or distribute medicines, safeguarding product integrity and public health.
"The restrictions imposed by sections 5 and 6 do not apply to anything which is done in a hospital by or under the supervision of a pharmacist... [7(1)]."
Verify source in source document →
Sections 7 to 9 provide exemptions to the licensing requirements for certain professionals and circumstances, such as pharmacists operating within hospitals or practitioners preparing herbal remedies. These exemptions recognize the practical necessities of healthcare delivery while maintaining regulatory oversight.
"The Minister may by order... provide for any other exemptions from the restrictions imposed by sections 5 and 6 that the Minister thinks fit. [9]."
Verify source in source document →
Section 9 empowers the Minister to grant further exemptions, allowing flexibility to adapt the regulatory regime to evolving healthcare practices and technologies without compromising safety.
Sections 10 through 19 detail procedural aspects including the maintenance of a register of licensed medicinal products (Section 10), application processes, criteria for licence grant or refusal, renewal, suspension, variation, and provisions for clinical trials (Section 18). These procedural safeguards ensure transparency, due process, and continual compliance monitoring.
"The licensing authority must maintain a register in which must be entered all medicinal products in respect of which product licences have been granted and remain in force. [10(1)]."
Verify source in source document →
"The Minister may by regulations provide for the conduct of clinical trials... [18]."
Verify source in source document →
Section 20 establishes offences and penalties for contraventions of licensing provisions, reinforcing the seriousness of compliance. Section 21 provides special defences for licence holders charged under Section 20, ensuring fairness in enforcement. Section 22 facilitates export by allowing issuance of certificates for medicinal products intended for export.
"Any person who contravenes any of the provisions of sections 5 and 6... shall be guilty of an offence... liable on conviction to a fine not exceeding $5,000 or to imprisonment for a term not exceeding 2 years or to both. [20(1), (6)]."
Verify source in source document →
"On the application of any person who proposes to export medicinal products... the licensing authority may issue... a certificate... [22]."
Verify source in source document →
Definitions in the Medicines Act 1975 and Their Significance
Clear definitions are critical for the effective application of the Medicines Act 1975. The Act defines key terms to delineate the scope of regulatory control and clarify licensing requirements.
"Except in accordance with a licence granted for the purposes of this section (called in this Act a product licence)... [5(1)]."
Verify source in source document →
The term "product licence" refers specifically to licences granted under Section 5 for the sale, supply, or export of medicinal products. This definition ensures that the licensing regime targets the appropriate activities.
"A person must not manufacture or assemble any medicinal product except in accordance with a licence granted for the purposes of this subsection (called in this Act a manufacturer’s licence). [6(2)]."
Verify source in source document →
"Manufacturer’s licence" is defined under Section 6(2) to regulate entities involved in the production or assembly of medicinal products, ensuring compliance with manufacturing standards.
"A person must not sell any medicinal product by way of wholesale dealing except in accordance with a licence granted for the purposes of this subsection (called in this Act a wholesale dealer’s licence). [6(3)]."
Verify source in source document →
"Wholesale dealer’s licence" applies to those engaged in wholesale distribution, maintaining control over the supply chain.
"‘veterinary biologics’ means aggressions, serums, viruses, toxins, tuberculin, mallein, Johnin, abortin, vaccines, micro‑organisms either living or killed, and products of micro‑organisms intended for use in the treatment or diagnosis of diseases of animals and birds; ‘veterinary centre’ means a veterinary centre established under section 54 of the Animals and Birds Act 1965. [7(5)]."
Verify source in source document →
These definitions clarify the scope of veterinary medicinal products and the relevant institutions, linking the Medicines Act with the Animals and Birds Act 1965 for comprehensive regulation of animal health products.
Penalties for Non-Compliance and Their Rationale
The Medicines Act 1975 imposes stringent penalties to deter unlawful manufacture, sale, or supply of medicinal products, thereby protecting public health and maintaining trust in the pharmaceutical system.
"Any person guilty of an offence under subsection (1), (2) or (3) shall be liable on conviction to a fine not exceeding $5,000 or to imprisonment for a term not exceeding 2 years or to both. [20(6)]."
Verify source in source document →
Section 20(6) prescribes significant penalties for offences under Sections 5 and 6, reflecting the serious risks posed by unlicensed medicinal products. The dual possibility of fines and imprisonment underscores the importance of compliance.
"Any person guilty of an offence under subsection (5) shall be liable on conviction to a fine not exceeding $2,000. [20(7)]."
Verify source in source document →
Section 20(7) imposes a lesser fine for failure to comply with notices issued under Section 19(2), balancing enforcement with proportionality for administrative breaches.
Cross-References to Other Legislation
The Medicines Act 1975 integrates with other legislative frameworks to ensure cohesive regulation, particularly concerning veterinary medicinal products.
"the Director‑General, Animal Health and Welfare appointed under section 3(1) of the Animals and Birds Act 1965... [4(1)(b)]."
Verify source in source document →
Section 4(1)(b) references the Animals and Birds Act 1965 for the appointment of the Director-General, Animal Health and Welfare, ensuring that veterinary medicinal products are regulated by the appropriate authority with expertise in animal health.
"‘veterinary centre’ means a veterinary centre established under section 54 of the Animals and Birds Act 1965. [7(5)]."
Verify source in source document →
Section 7(5) defines "veterinary centre" by cross-reference to the Animals and Birds Act 1965, facilitating consistent regulation of veterinary establishments across statutes.
Conclusion
The Medicines Act 1975 establishes a robust regulatory framework that governs the licensing, manufacture, sale, and export of medicinal products in Singapore. Its provisions ensure that only qualified entities handle medicinal products, thereby safeguarding public health. The Act’s detailed definitions, procedural requirements, and penalties for non-compliance reflect a comprehensive approach to pharmaceutical regulation. Cross-references to the Animals and Birds Act 1965 further integrate veterinary medicinal product regulation, demonstrating legislative coherence.
Sections Covered in This Analysis
- Section 4 – Licensing Authority
- Section 5 – Prohibition on Sale, Supply, Export Without Product Licence
- Section 6 – Prohibition on Manufacture and Wholesale Dealing Without Licence
- Sections 7-9 – Exemptions
- Section 9 – Ministerial Power to Grant Exemptions
- Section 10 – Register of Licensed Medicinal Products
- Section 18 – Clinical Trials Regulations
- Section 19 – Notices and Compliance
- Section 20 – Offences and Penalties
- Section 21 – Special Defences for Licence Holders
- Section 22 – Export Certificates
- Section 7(5) – Definitions of Veterinary Biologics and Veterinary Centre
- Cross-References to Animals and Birds Act 1965, Sections 3(1) and 54
Source Documents
For the authoritative text, consult SSO.